Innovation and competition in advanced therapy medicinal products

Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text...

Descripción completa

Detalles Bibliográficos
Autores principales: Seoane‐Vazquez, Enrique, Shukla, Vaishali, Rodriguez‐Monguio, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404110/
https://www.ncbi.nlm.nih.gov/pubmed/30770338
http://dx.doi.org/10.15252/emmm.201809992
_version_ 1783400800108675072
author Seoane‐Vazquez, Enrique
Shukla, Vaishali
Rodriguez‐Monguio, Rosa
author_facet Seoane‐Vazquez, Enrique
Shukla, Vaishali
Rodriguez‐Monguio, Rosa
author_sort Seoane‐Vazquez, Enrique
collection PubMed
description Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text]
format Online
Article
Text
id pubmed-6404110
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64041102019-03-18 Innovation and competition in advanced therapy medicinal products Seoane‐Vazquez, Enrique Shukla, Vaishali Rodriguez‐Monguio, Rosa EMBO Mol Med Opinion Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text] John Wiley and Sons Inc. 2019-02-15 2019-03 /pmc/articles/PMC6404110/ /pubmed/30770338 http://dx.doi.org/10.15252/emmm.201809992 Text en © 2019 The Authors. Published under the terms of the CC BY 4.0 license This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion
Seoane‐Vazquez, Enrique
Shukla, Vaishali
Rodriguez‐Monguio, Rosa
Innovation and competition in advanced therapy medicinal products
title Innovation and competition in advanced therapy medicinal products
title_full Innovation and competition in advanced therapy medicinal products
title_fullStr Innovation and competition in advanced therapy medicinal products
title_full_unstemmed Innovation and competition in advanced therapy medicinal products
title_short Innovation and competition in advanced therapy medicinal products
title_sort innovation and competition in advanced therapy medicinal products
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404110/
https://www.ncbi.nlm.nih.gov/pubmed/30770338
http://dx.doi.org/10.15252/emmm.201809992
work_keys_str_mv AT seoanevazquezenrique innovationandcompetitioninadvancedtherapymedicinalproducts
AT shuklavaishali innovationandcompetitioninadvancedtherapymedicinalproducts
AT rodriguezmonguiorosa innovationandcompetitioninadvancedtherapymedicinalproducts

Ejemplares similares